北京医学
北京醫學
북경의학
BEIJING MEDICAL JOURNAL
2015年
1期
29-32
,共4页
维持性血液透析%性功能障碍%生活质量%女性
維持性血液透析%性功能障礙%生活質量%女性
유지성혈액투석%성공능장애%생활질량%녀성
Maintenance hemodialysis%Sexual dysfunction%Quality of life%Female
目的:研究维持性透析女性患者性功能障碍发病情况、表现形式及相关影响因素,同时评估她们的生活质量。方法选择维持性血液透析女性患者50例,总结患者的一般资料(病例组)。通过问卷调查方式调查女性性功能指数FSFI及生活质量(SF-36量表中文版),评价患者性功能状况以及评估患者的生活质量。总结患者实验室检查结果(包括血肌酐、血红蛋白、血浆白蛋白和甲状旁腺激素等)。选取健康成年女性为对照组,行问卷调查。对2组受调查者一般资料和问卷结果进行统计分析。结果病例组性功能障碍发生率为73%,高于对照组的40%。病例组FSFI量表总分平均分数为18.06±8.41低于对照组的26.73±4.63(P<0.01),且各方面得分明显低于对照组。 SF-36量表显示各项指标均低于对照组,P<0.001。多因素logistic分析表明,性功能障碍的发生与患者的年龄、病程、血浆白蛋白、血肌酐、甲状旁腺激素等无关。贫血、甘油三酯(OR=4.514,95% CI:1.119-18.201)、总胆固醇(OR=6.564,95%CI:1.449-29.723)和β受体阻滞剂(OR=10.0,95%CI:1.342-74.511),是维持性血液透析女性患者发生性功能障碍的危险因素,使用r-HuEpo(OR=0.099,95%CI:0.010-0.949)性功能障碍发生的保护性因素。结论维持性透析女性患者性功能障碍发病率高,性功能及生活质量均低于正常人。性功能障碍发生与贫血、血脂异常和应用β受体阻滞剂有关。
目的:研究維持性透析女性患者性功能障礙髮病情況、錶現形式及相關影響因素,同時評估她們的生活質量。方法選擇維持性血液透析女性患者50例,總結患者的一般資料(病例組)。通過問捲調查方式調查女性性功能指數FSFI及生活質量(SF-36量錶中文版),評價患者性功能狀況以及評估患者的生活質量。總結患者實驗室檢查結果(包括血肌酐、血紅蛋白、血漿白蛋白和甲狀徬腺激素等)。選取健康成年女性為對照組,行問捲調查。對2組受調查者一般資料和問捲結果進行統計分析。結果病例組性功能障礙髮生率為73%,高于對照組的40%。病例組FSFI量錶總分平均分數為18.06±8.41低于對照組的26.73±4.63(P<0.01),且各方麵得分明顯低于對照組。 SF-36量錶顯示各項指標均低于對照組,P<0.001。多因素logistic分析錶明,性功能障礙的髮生與患者的年齡、病程、血漿白蛋白、血肌酐、甲狀徬腺激素等無關。貧血、甘油三酯(OR=4.514,95% CI:1.119-18.201)、總膽固醇(OR=6.564,95%CI:1.449-29.723)和β受體阻滯劑(OR=10.0,95%CI:1.342-74.511),是維持性血液透析女性患者髮生性功能障礙的危險因素,使用r-HuEpo(OR=0.099,95%CI:0.010-0.949)性功能障礙髮生的保護性因素。結論維持性透析女性患者性功能障礙髮病率高,性功能及生活質量均低于正常人。性功能障礙髮生與貧血、血脂異常和應用β受體阻滯劑有關。
목적:연구유지성투석녀성환자성공능장애발병정황、표현형식급상관영향인소,동시평고저문적생활질량。방법선택유지성혈액투석녀성환자50례,총결환자적일반자료(병례조)。통과문권조사방식조사녀성성공능지수FSFI급생활질량(SF-36량표중문판),평개환자성공능상황이급평고환자적생활질량。총결환자실험실검사결과(포괄혈기항、혈홍단백、혈장백단백화갑상방선격소등)。선취건강성년녀성위대조조,행문권조사。대2조수조사자일반자료화문권결과진행통계분석。결과병례조성공능장애발생솔위73%,고우대조조적40%。병례조FSFI량표총분평균분수위18.06±8.41저우대조조적26.73±4.63(P<0.01),차각방면득분명현저우대조조。 SF-36량표현시각항지표균저우대조조,P<0.001。다인소logistic분석표명,성공능장애적발생여환자적년령、병정、혈장백단백、혈기항、갑상방선격소등무관。빈혈、감유삼지(OR=4.514,95% CI:1.119-18.201)、총담고순(OR=6.564,95%CI:1.449-29.723)화β수체조체제(OR=10.0,95%CI:1.342-74.511),시유지성혈액투석녀성환자발생성공능장애적위험인소,사용r-HuEpo(OR=0.099,95%CI:0.010-0.949)성공능장애발생적보호성인소。결론유지성투석녀성환자성공능장애발병솔고,성공능급생활질량균저우정상인。성공능장애발생여빈혈、혈지이상화응용β수체조체제유관。
Objective To investigate the prevalence, manifestation and related factors of sexual dysfunction in female patients with maintenance hemodialysis,and assesse their life quality. Methods Fifty female patients were recruited into this study from Beijing Daxing Peopleˊs Hospital. By using the questionnaires, all patients were requested to finish two surveys independently, Female Sexual Function Index (FSFI) and SF-36, to assess their sexual function, examine the related factors of sexual dysfunction and evaluate their quality of life. In the meantime, all patientsˊ general clinical data, such as age, weight, etiologies of renal failure, course of disease, medical history and laboratory results, were recorded. An age-matched married control group of 30 volunteers were recruited to this study and finished two questionnaires. All general data and survey responses from the two groups were analyzed. Results The prevalence of sexual dysfunction was higher in the Group Patients than the Group Control (73%vs. 40%). The total scores of FSFI in Group Patients was significantly lower than those of Group Control (18.06±8.41 vs. 26.73±4.63,P< 0.01). Similarly, each aspects of FSFI were significantly lower than those in Group Control, P< 0.01. And according to SF-36 survey response, all dimensions in Group Patinets were much lower in Group Control, P< 0.001. By using of Logsitic regression analysis, it demonstrated that the age, duration, Alb, Scr, PTH and so on was not associated with sexual dysfunction. Anemia, dyslipidemia and using of β-blocker (OR=10.0, 95%CI:1.342-74.511) were risk factors for sexual dysfunction in female patients with maintenance hemodialysis, however, r-HuEpo (OR=0.099; 95%CI:0.010-0.949) was protective factors. Conclusion Sexual dysfunction is common in female patients with maintenance hemodialysis, and their status of sexual function and quality of life are much lower than healthy population. Anemia, dyslipidemia and using of β-blocker are associated with sexual dysfunction.